(CUSIP Nos. 45900T AA0 / E6R69L AA2;ISIN Nos. US45900TAA07 / USE6R69LAA27) International Airport Finance, S.A. (the “Issuer”) announces the expected settlement date of its previously announced consent solicitation (the “Consent Solicitation”), where it sought to obtain the consents (the “Consents”) from registered holders (the “Holders”) of its 12.000% Senior Secured Notes due 2033 (the “Notes”), […]

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ:TVRD) concerning possible violations of federal securities laws. On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing its STAT3 inhibitor drug,

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Firefly Aerospace Inc. ("Firefly" or the "Company") (NASDAQ:FLY) and certain officers.�� The class action, filed in the United States District Court for the Western District of Texas, and docketed under 25-cv-01812,

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE:LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rci-hospitality-holdings-inc-lawsuit-submission-form?prid=176859&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

(NASDAQ:CNTA), BOSTON and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten public offering of 11,627,907 American Depositary Shares (“ADSs”), each representing one ordinary share, at a price to the public of $21.50 per ADS. The aggregate gross proceeds to Centessa

Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares GlobeNewswire November 12, 2025 BOSTON and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten public offering of 11,627,907 American Depositary Shares (“ADSs”), each representing one ordinary share, at

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / If you suffered a loss on your Marex Group plc (NASDAQ:MRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marex-group-plc-lawsuit-submission-form?prid=176856&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / November 11, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=176857&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

The Report on State Grid's Contribution to Global Security Initiative was released during the “Beautiful Bays, Better Lives” Ocean Ecological Civilization Storytelling Session held at the China Pavilion of the 30th UN Climate Change Conference. This marks the first contribution report by a Chinese enterprise on the implementation of the Global Security Initiative. It is